Login Register Cart 0
Generic placeholder image

Combinatorial Chemistry & High Throughput Screening

Editor-in-Chief

ISSN (Print): 1386-2073
ISSN (Online): 1875-5402

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Research Article

Penehyclidine Hydrochloride Protects Rat Cardiomyocytes from Ischemia- Reperfusion Injury by Platelet-derived Growth Factor-B

Author(s): Yan Lu, Congna Zi, Liang Zhang, Boqun Cui, Ling Li and Jun Ma*

Volume 26, Issue 6, 2023

Published on: 26 August, 2022

Page: [1204 - 1213] Pages: 10

DOI: 10.2174/1386207325666220715090505

open access plus

Abstract

Aims and Objective: The lack of effective treatments for myocardial ischemiareperfusion (MI-R) injury severely restricts the effectiveness of the treatment of ischemic heart disease. In the present research, we aimed to investigate the protective effect and molecular mechanism of penehyclidine hydrochloride (PHC) on MI-R cells.

Methods: Cell viability was quantified using CCK8. Cell apoptosis was analyzed using flow cytometry. Western blot and Elisa assays were used for the detection of target proteins.

Results: PHC pretreatment attenuated the inhibition of cell viability and decreased the percentage of apoptosis induced by simulated ischemia reperfusion (SIR). Platelet-derived growth factor B (PDGF-B) and its downstream AKT pathway were activated in PHC pretreated cells. After siRNAPDGF- B transfection, cell viability was inhibited and apoptosis was activated in PHC pretreated SIR cells, suggesting that PHC protected cells from SIR. PDGF-B knockdown also increased the levels of CK, LDH, IL-6 and TNF-α in PHC pretreated SIR cells. The effect of AKT inhibitor on H9C2 cells was consistent with that of PDGF-B knockdown.

Conclusion: PHC pretreatment can protect cardiomyocytes from the decrease of cell activity and the increase of apoptosis caused by reperfusion through up-regulating PDGF-B to activate PI3K pathway. Our study indicates that PHC is a potential drug to protect cells from reperfusion injury and PDGF-B is a potential target for preventing MI-R injury.

Keywords: Apoptosis, cell viability, inflammatory factors, myocardial ischemia-reperfusion injury, penehyclidine hydrochloride, H9C2.

« Previous Next »
Graphical Abstract

[1]
Peng, H.; Abdel-Latif, A. Cellular therapy for ischemic heart disease: An update. Adv. Exp. Med. Biol., 2019, 1201, 195-213.
[http://dx.doi.org/10.1007/978-3-030-31206-0_10] [PMID: 31898788]
[2]
Mokhtari-Zaer, A.; Marefati, N.; Atkin, S.L.; Butler, A.E.; Sahebkar, A. The protective role of curcumin in myocardial ischemia-reperfusion injury. J. Cell. Physiol., 2018, 234(1), 214-222.
[http://dx.doi.org/10.1002/jcp.26848] [PMID: 29968913]
[3]
Kalogeris, T.; Baines, C.P.; Krenz, M.; Korthuis, R.J. Ischemia/reperfusion. Compr. Physiol., 2016, 7(1), 113-170.
[http://dx.doi.org/10.1002/cphy.c160006] [PMID: 28135002]
[4]
Anzell, A.R.; Maizy, R.; Przyklenk, K.; Sanderson, T.H. Mitochondrial quality control and disease: Insights into ischemia-reperfusion injury. Mol. Neurobiol., 2018, 55(3), 2547-2564.
[http://dx.doi.org/10.1007/s12035-017-0503-9] [PMID: 28401475]
[5]
Del Re, D.P.; Amgalan, D.; Linkermann, A.; Liu, Q.; Kitsis, R.N. Fundamental mechanisms of regulated cell death and implications for heart disease. Physiol. Rev., 2019, 99(4), 1765-1817.
[http://dx.doi.org/10.1152/physrev.00022.2018] [PMID: 31364924]
[6]
Wang, Y.; Gao, Y.; Ma, J. Pleiotropic effects and pharmacological properties of penehyclidine hydrochloride. Drug Des. Devel. Ther., 2018, 12, 3289-3299.
[http://dx.doi.org/10.2147/DDDT.S177435] [PMID: 30323561]
[7]
Xiao, H.T.; Liao, Z.; Tong, R.S. Penehyclidine hydrochloride: A potential drug for treating COPD by attenuating Toll-like receptors. Drug Des. Devel. Ther., 2012, 6, 317-322.
[http://dx.doi.org/10.2147/DDDT.S36555] [PMID: 23139625]
[8]
Wang, J.; Ren, Y.; Zhu, Y.; Chen, J.W.; Zhu, M.M.; Xu, Y.J.; Tan, Z.M. Effect of penehyclidine hydrochloride on the incidence of intra-operative awareness in Chinese patients undergoing breast cancer surgery during general anaesthesia. Anaesthesia, 2013, 68(2), 136-141.
[http://dx.doi.org/10.1111/anae.12092] [PMID: 23237605]
[9]
Liang, M.J.; Zhang, Y. Clinical analysis of penehyclidine hydrochloride combined with hemoperfusion in the treatment of acute severe organophosphorus pesticide poisoning. Genet. Mol. Res., 2015, 14(2), 4914-4919.
[http://dx.doi.org/10.4238/2015.May.11.24] [PMID: 25966266]
[10]
Zhang, K.; Che, S.; Pan, C.; Su, Z.; Zheng, S.; Yang, S.; Zhang, H.; Li, W.; Wang, W.; Liu, J. The SHH/Gli axis regulates CD90-mediated liver cancer stem cell function by activating the IL6/JAK2 pathway. J. Cell. Mol. Med., 2018, 22(7), 3679-3690.
[http://dx.doi.org/10.1111/jcmm.13651] [PMID: 29722127]
[11]
Zhao, H.; Wang, P.; Ma, C.; Wang, C. Smoking attenuates efficacy of penehyclidine hydrochloride in acute respiratory distress syndrome induced by lipopolysaccharide in rats. Med. Sci. Monit., 2019, 25, 7295-7305.
[http://dx.doi.org/10.12659/MSM.917037] [PMID: 31562811]
[12]
Xiao, H.; Shi, T.; Han, L.; Tong, R.; Liao, Z. Mechanism of penehyclidine hydrochloride on a dysmenorrhea rat model. Drug Dev. Res., 2019, 80(3), 325-332.
[http://dx.doi.org/10.1002/ddr.21500] [PMID: 30511353]
[13]
Tan, H.; Chen, L.; Ma, J. Penehyclidine hydrochloride post-conditioning reduces ischemia/reperfusion-induced cardiomyocyte apoptosis in rats. Exp. Ther. Med., 2017, 14(5), 4272-4278.
[http://dx.doi.org/10.3892/etm.2017.5089] [PMID: 29104640]
[14]
Yu, C.; Wang, J. Neuroprotective effect of penehyclidine hydrochloride on focal cerebral ischemia-reperfusion injury. Neural Regen. Res., 2013, 8(7), 622-632.
[PMID: 25206707]
[15]
Gong, P.; Zhang, Y.; Liu, H.; Zhao, G.K.; Jiang, H. Effects of penehyclidine hydrochloride on the splanchnic perfusion of patients with septic shock. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue, 2008, 20(3), 183-186.
[PMID: 18328136]
[16]
Li, J.; Hu, H.P.; Li, Y.; Shao, W.; Zhang, J.Z.; Wang, L.M. Influences of remifentanil on myocardial ischemia-reperfusion injury and the expressions of Bax and Bcl-2 in rats. Eur. Rev. Med. Pharmacol. Sci., 2018, 22(24), 8951-8960.
[PMID: 30575939]
[17]
Zhang, Y.L.; Liu, X.M.; Liu, H.S.; Lou, J.L.; Zheng, H.; Huang, Q.F. Effect of Xinnao Shutong capsule on apoptosis after cerebral ischemia and reperfusion in rats. Zhongguo Zhongyao Zazhi, 2008, 33(10), 1188-1191.
[PMID: 18720874]
[18]
Saotome, M.; Katoh, H.; Yaguchi, Y.; Tanaka, T.; Urushida, T.; Satoh, H.; Hayashi, H. Transient opening of mitochondrial permeability transition pore by reactive oxygen species protects myocardium from ischemia-reperfusion injury. Am. J. Physiol. Heart Circ. Physiol., 2009, 296(4), H1125-H1132.
[http://dx.doi.org/10.1152/ajpheart.00436.2008] [PMID: 19202002]
[19]
Szydlowska, K.; Tymianski, M. Calcium, ischemia and excitotoxicity. Cell Calcium, 2010, 47(2), 122-129.
[http://dx.doi.org/10.1016/j.ceca.2010.01.003] [PMID: 20167368]
[20]
Frangogiannis, N.G. Pathophysiology of myocardial infarction. Compr. Physiol., 2015, 5(4), 1841-1875.
[http://dx.doi.org/10.1002/cphy.c150006] [PMID: 26426469]
[21]
Yao, L.; Chen, H.; Wu, Q.; Xie, K. Hydrogen-rich saline alleviates inflammation and apoptosis in myocardial I/R injury via PINK-mediated autophagy. Int. J. Mol. Med., 2019, 44(3), 1048-1062.
[http://dx.doi.org/10.3892/ijmm.2019.4264] [PMID: 31524220]
[22]
Wu, X.J.; Liu, H.M.; Song, X.M.; Zhao, B.; Leng, Y.; Wang, E.Y.; Zhan, L.Y.; Meng, Q.T.; Xia, Z.Y. Penehyclidine hydrochloride inhibits TLR4 signaling and inflammation, and attenuates blunt chest trauma and hemorrhagic shock-induced acute lung injury in rats. Mol. Med. Rep., 2018, 17(5), 6327-6336.
[http://dx.doi.org/10.3892/mmr.2018.8644] [PMID: 29488614]
[23]
Wang, T.; Leng, Y.F.; Zhang, Y.; Kang, Y.Q.; Xue, X.; Zhang, Y. Preventive effects of ischemic postconditioning and penehyclidine hydrochloride on gastric against ischemia-reperfusion injury in rats. Zhonghua Yi Xue Za Zhi, 2011, 91(16), 1130-1135.
[PMID: 21609599]
[24]
Borkham-Kamphorst, E.; Weiskirchen, R. The PDGF system and its antagonists in liver fibrosis. Cytokine Growth Factor Rev., 2016, 28, 53-61.
[http://dx.doi.org/10.1016/j.cytogfr.2015.10.002] [PMID: 26547628]
[25]
Salha, S.; Gehmert, S.; Brébant, V.; Anker, A.; Loibl, M.; Prantl, L.; Gehmert, S. PDGF regulated migration of mesenchymal stem cells towards malignancy acts via the PI3K signaling pathway. Clin. Hemorheol. Microcirc., 2018, 70(4), 543-551.
[http://dx.doi.org/10.3233/CH-189319] [PMID: 30347613]
[26]
Chen, J.; Yuan, W.; Wu, L.; Tang, Q.; Xia, Q.; Ji, J.; Liu, Z.; Ma, Z.; Zhou, Z.; Cheng, Y.; Shu, X. PDGF-D promotes cell growth, aggressiveness, angiogenesis and EMT transformation of colorectal cancer by activation of Notch1/Twist1 pathway. Oncotarget, 2017, 8(6), 9961-9973.
[http://dx.doi.org/10.18632/oncotarget.14283] [PMID: 28035069]
[27]
Corsinovi, D.; Giannetti, K.; Cericola, A.; Naef, V.; Ori, M. PDGF-B: The missing piece in the mosaic of PDGF family role in craniofacial development. Dev. Dyn., 2019, 248(7), 603-612.
[http://dx.doi.org/10.1002/dvdy.47] [PMID: 31070827]
[28]
Fredriksson, L.; Li, H.; Eriksson, U. The PDGF family: Four gene products form five dimeric isoforms. Cytokine Growth Factor Rev., 2004, 15(4), 197-204.
[http://dx.doi.org/10.1016/j.cytogfr.2004.03.007] [PMID: 15207811]
[29]
Tuuminen, R.; Dashkevich, A.; Keränen, M.A.; Raissadati, A.; Krebs, R.; Jokinen, J.J.; Arnaudova, R.; Rouvinen, E.; Ylä-Herttuala, S.; Nykänen, A.I.; Lemström, K.B. Platelet-derived growth factor-B protects rat cardiac allografts from ischemia-reperfusion injury. Transplantation, 2016, 100(2), 303-313.
[http://dx.doi.org/10.1097/TP.0000000000000909] [PMID: 26371596]
[30]
Reyhani, V.; Tsioumpekou, M.; van Wieringen, T.; Rask, L.; Lennartsson, J.; Rubin, K. PDGF-BB enhances collagen gel contraction through a PI3K-PLCγ-PKC-cofilin pathway. Sci. Rep., 2017, 7(1), 8924.
[http://dx.doi.org/10.1038/s41598-017-08411-1] [PMID: 28827622]
[31]
Yang, Y.; Zhao, L.; Ma, J. Penehyclidine hydrochloride preconditioning provides cardiac protection in a rat model of myocardial ischemia/reperfusion injury via the mechanism of mitochondrial dynamics mechanism. Eur. J. Pharmacol., 2017, 813, 130-139.
[http://dx.doi.org/10.1016/j.ejphar.2017.07.031] [PMID: 28755984]
[32]
Lin, D.; Ma, J.; Xue, Y.; Wang, Z. Penehyclidine hydrochloride preconditioning provides cardioprotection in a rat model of myocardial ischemia/reperfusion injury. PLoS One, 2015, 10(12)e0138051
[http://dx.doi.org/10.1371/journal.pone.0138051] [PMID: 26632817]
[33]
Feng, M.; Wang, L.; Chang, S.; Yuan, P. Penehyclidine hydrochloride regulates mitochondrial dynamics and apoptosis through p38MAPK and JNK signal pathways and provides cardioprotection in rats with myocardial ischemia-reperfusion injury. Eur. J. Pharm. Sci., 2018, 121, 243-250.
[http://dx.doi.org/10.1016/j.ejps.2018.05.023] [PMID: 29860115]
[34]
Tan, H.; Lin, D.; Wang, Z.; Yang, Y.; Ma, J. Cardioprotective time-window of Penehyclidine hydrochloride postconditioning: A rat study. Eur. J. Pharmacol., 2017, 812, 48-56.
[http://dx.doi.org/10.1016/j.ejphar.2017.07.003] [PMID: 28684235]

Rights & Permissions Print Cite
Article Metrics
33
2
© 2024 Bentham Science Publishers | Privacy Policy